153 related articles for article (PubMed ID: 17589196)
21. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
Soriano V; Mocroft A; Rockstroh J; Ledergerber B; Knysz B; Chaplinskas S; Peters L; Karlsson A; Katlama C; Toro C; Kupfer B; Vogel M; Lundgren J;
J Infect Dis; 2008 Nov; 198(9):1337-44. PubMed ID: 18767985
[TBL] [Abstract][Full Text] [Related]
22. [Changes in bone marrow among HIV-positive and HIV-negative parenteral drug addicts].
González Aza C; Grilo Reina A; López Martín JC; Torre Sabariego A; Martínez Estéfano E; López Lacomba D; Herrera Díaz A; Moreno Garrido D
Med Clin (Barc); 1995 Jan; 104(3):89-91. PubMed ID: 7877370
[TBL] [Abstract][Full Text] [Related]
23. Genetic drift of parvovirus B19 is found in AIDS patients with persistent B19 infection.
Hung CC; Sheng WH; Lee KL; Yang SJ; Chen MY
J Med Virol; 2006 Nov; 78(11):1374-84. PubMed ID: 16998895
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
[TBL] [Abstract][Full Text] [Related]
27. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population.
Fabris P; Baldo V; Baldovin T; Bellotto E; Rassu M; Trivello R; Tramarin A; Tositti G; Floreani A
J Clin Gastroenterol; 2008; 42(5):527-32. PubMed ID: 18277889
[TBL] [Abstract][Full Text] [Related]
28. Branched DNA technology in molecular diagnostics.
Tsongalis GJ
Am J Clin Pathol; 2006 Sep; 126(3):448-53. PubMed ID: 16880139
[TBL] [Abstract][Full Text] [Related]
29. Parvoviruses PARV4/5 in hepatitis C virus-infected patient.
Fryer JF; Lucas SB; Padley D; Baylis SA
Emerg Infect Dis; 2007 Jan; 13(1):175-6. PubMed ID: 17370542
[No Abstract] [Full Text] [Related]
30. Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4.
Schneider B; Fryer JF; Oldenburg J; Brackmann HH; Baylis SA; Eis-Hübinger AM
Haemophilia; 2008 Sep; 14(5):978-86. PubMed ID: 18565125
[TBL] [Abstract][Full Text] [Related]
31. First report of human parvovirus 4 detection in Iran.
Asiyabi S; Nejati A; Shoja Z; Shahmahmoodi S; Jalilvand S; Farahmand M; Gorzin AA; Najafi A; Haji Mollahoseini M; Marashi SM
J Med Virol; 2016 Aug; 88(8):1314-8. PubMed ID: 26812938
[TBL] [Abstract][Full Text] [Related]
32. A third genotype of the human parvovirus PARV4 in sub-Saharan Africa.
Simmonds P; Douglas J; Bestetti G; Longhi E; Antinori S; Parravicini C; Corbellino M
J Gen Virol; 2008 Sep; 89(Pt 9):2299-2302. PubMed ID: 18753240
[TBL] [Abstract][Full Text] [Related]
33. Variants of parvovirus B19: bioinformatical evaluation of nested PCR assays.
Bergallo M; Costa C; Sidoti F; Novelli M; Ponti R; Castagnoli C; Merlino C; Bernengo MG; Cavallo R
Intervirology; 2008; 51(2):75-80. PubMed ID: 18431072
[TBL] [Abstract][Full Text] [Related]
34. HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.
Quarleri JF; Bolcic FM; Bouzas MB; Laufer N; Gómez Carrillo M; Mammana L; Kaufman S; Pérez H; Cahn P; Salomon H
Acta Gastroenterol Latinoam; 2007 Jun; 37(2):76-83. PubMed ID: 17684937
[TBL] [Abstract][Full Text] [Related]
35. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals.
Fryer JF; Delwart E; Hecht FM; Bernardin F; Jones MS; Shah N; Baylis SA
Transfusion; 2007 Jun; 47(6):1054-61. PubMed ID: 17524097
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and significance of human parvovirus variants in skin from primary cutaneous T cell lymphomas, inflammatory dermatoses and healthy subjects.
Sidoti F; Fierro MT; Costa C; Ponti R; Bergallo M; Comessatti A; Fumagalli M; Novelli M; Merlino C; Cavallo R; Bernengo MG
Arch Dermatol Res; 2009 Oct; 301(9):647-52. PubMed ID: 19387672
[TBL] [Abstract][Full Text] [Related]
37. Novel parvovirus and related variant in human plasma.
Fryer JF; Kapoor A; Minor PD; Delwart E; Baylis SA
Emerg Infect Dis; 2006 Jan; 12(1):151-4. PubMed ID: 16494735
[TBL] [Abstract][Full Text] [Related]
38. Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.
Micalessi MI; Gérard C; Ameye L; Plasschaert S; Brochier B; Vranckx R
J Med Virol; 2008 Apr; 80(4):640-5. PubMed ID: 18297717
[TBL] [Abstract][Full Text] [Related]
39. Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C.
Liakina V; Speiciene D; Irnius A; Valantinas J
Med Sci Monit; 2009 Apr; 15(4):PH17-23. PubMed ID: 19333213
[TBL] [Abstract][Full Text] [Related]
40. Influence of HTLV-2 infection on hepatitis C virus replication in HIV-positive patients.
Toro C; Bassani S; Ríos P; Jiménez V; Camino N; Soriano V
J Clin Virol; 2005 Apr; 32(4):338-9. PubMed ID: 15780816
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
